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What is already known about the topic?
•• Healthcare systems globally are faced with the challenge of how best to support growing older populations with com-
plex medical and social needs.
•• Models of care incorporating patient empowerment strategies are being increasingly adopted in response to these popu-
lation changes with the aim of alleviating the impact of morbidity on people’s lives and reducing the demands placed on 
health and social care services.
•• Little is known about the application or impact of empowerment strategies for patients with advanced, life-limiting 
illness(s).
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Abstract
Background: Patient empowerment, defined as ‘a process through which people gain greater control over decisions and actions 
affecting their health’ (World Health Organization) is a key theme within global health and social care strategies. The benefits of 
incorporating empowerment strategies in care are well documented, but little is known about their application or impact for patients 
with advanced, life-limiting illness(s).
Aim: To identify and synthesise the international evidence on patient empowerment for adults with advanced, life-limiting illness(s).
Design: Systematic review (PROSPERO no. 46113) with critical interpretive synthesis methodology.
Data sources: Five databases (MEDLINE, Embase, CINHAL, PsycINFO and Cochrane) were searched from inception to March 2018. 
Grey literature and reference list/citation searches of included papers were undertaken. Inclusion criteria: empirical research involving 
patients with advanced life-limiting illness including descriptions of, or references to, patient empowerment within the study results.
Results: In all, 13 papers met inclusion criteria. Two qualitative studies explored patient empowerment as a study objective. Six 
papers evaluated interventions, referencing patient empowerment as an incidental outcome. The following themes were identified 
from the interpretive synthesis: self-identity, personalised knowledge in theory and practice, negotiating personal and healthcare 
relationships, acknowledgement of terminal illness, and navigating continued losses.
Conclusion: There are features of empowerment, for patients with advanced life-limiting illness distinct to those of other patient 
groups. Greater efforts should be made to progress the empowerment of patients nearing the end of their lives. We propose that the 
identified themes may provide a useful starting point to guide the assessment of existing or planned services and inform future research.
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What this paper adds?
•• To our knowledge, this is the first review to explore the concept of patient empowerment for adults living with advanced, 
life-limiting illness.
•• There are features of empowerment, for patients with advanced life-limiting illness, distinct to those of other patient 
groups. Key differences relate to the continued physical and psychosocial challenges this group encounter, producing 
contrasting patient empowerment foci.
•• Our review found no evidence of attempts to incorporate patient empowerment into the design or evaluation of ser-
vices that support people with advanced life-limiting illness.
Implications for practice, theory or policy
•• We would propose that the identified themes and conceptual model produced in review may provide a useful starting 
point to guide the assessment of existing services and development of a new dialogue surrounding patient participation 
in the design of services and interventions.
Background
The impact of the continuing rise in global average life 
expectancy is already apparent in many countries with 
growing older populations with complex medical and 
social needs.1–3 The concept of ‘patient empowerment’ has 
gained traction in recent years, responding to these popula-
tion challenges with the aim of alleviating the impact of 
morbidity on people’s lives and limiting the demands high 
levels of morbidity place on health and social care 
services.4
There are various definitions and applications of patient 
empowerment (termed ‘patient activation’, in some texts) 
used within healthcare, with the largest body of research in 
long-term conditions. Here, the empowerment paradigm 
involves patients reclaiming their responsibilities to 
improve and maintain their health, in parallel with a refor-
mation of the patient–doctor relationship4–6 that encour-
ages equitable partnerships over an authoritative dynamic.7 
Self-management and self-efficacy are key features within 
the majority of patient empowerment constructs, with a 
growing number of measures used in practice to assess, 
monitor and promote these qualities.5,8,9 There is increas-
ing evidence that patient empowerment is effective and 
beneficial. Helping patients to achieve improved health 
states reduces the impact on services and engenders con-
tinued participation and motivation from healthcare pro-
fessionals (HCPs) and patients.10,11 Consequently, patient 
empowerment has gained the attention of policy makers on 
a global scale, with mandates for, and investment into, ini-
tiatives and service structures to empower patients now 
commonplace.12–15
Existing empowerment tools and models assume a 
degree of reversibility to patients’ health states and/or the 
potential to inhibit the progression of a negative health 
state by means of improved self-care, lifestyle choices and 
relations with HCPs and services.5,8,11,16 From the perspec-
tive of advanced illness, when there is not the potential for 
health gains, or when disability impedes function and 
capacity to self-manage and forces dependency on others, 
these tools and models may cease to be appropriate. This 
results in this population being inappropriately assessed 
and subsequently underserved.
This review intends to appraise the international evi-
dence surrounding definitions and/or concepts pertaining 
to patient empowerment for persons living with advanced, 
life-limiting disease, with the aim of understanding 
whether patients can still be ‘empowered’ in the context of 
advanced, terminal illness and/or whether these patients 
fall outside of the measures, models and services designed 
around the current understanding and constructs of ‘patient 
empowerment’.
Research questions
1. How has empirical research defined ‘patient 
empowerment’ for adults in the advanced stages of 
a life-limiting illness.
2. What factors/themes are associated with patient 
empowerment for adults in the advanced stages of 
a life-limiting illness.
3. Which interventions or exposures seek to support 
or promote patient empowerment for adults in the 
advanced stages of a life-limiting illness.
Methods
Design
We followed systematic review best practices to formulate 
a search strategy underpinned by study objectives and 
inclusion criteria, as specified in our registered protocol.17 
Which is combined with critical interpretive synthesis18 
methodology to integrate data across studies.
Critical interpretive synthesis methodology, developed 
by Dixon-Woods et al.,18 is an iterative approach designed 
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to appraise and synthesise complex and heterogeneous 
quantitative and qualitative evidence, in a bid to develop a 
novel definition, concept or theory. We specifically 
selected this method for its ability to inform the review 
question, identification and selection of evidence, as well 
as synthesis of evidence. The orientation of critical inter-
pretive synthesis towards theory generation makes its 
practice distinct from that of meta-ethnography and other 
qualitative synthesis methods.
We adopted this methodology based on the findings of 
our initial scoping of the literature, which aimed to identify 
empirical research on empowerment for adults in the 
advanced stages of a life-limiting illness This exercise iden-
tified a small body of literature of methodological heteroge-
neity, highlighting the challenges of attempting to collate 
and synthesise evidence where the phenomenon of interest 
is not well specified and where evidence is very heterogene-
ous in both type and purpose. These findings, and our aim to 
contrast our results with existing evidence on empowerment 
for other patient groups and to build conceptual understand-
ing, informed our decision to conduct a critical interpretive 
synthesis, rather than use traditional aggregative review 
methodology. This enabled insights into the concepts under-
pinning empowerment to emerge through an iterative, 
dynamic and critical synthesis of the literature.
Search strategy
Search terms (Appendix 1) were generated from the exist-
ing research and theoretical literature surrounding patient 
empowerment and activation.4,6,16,19,20 We subsequently 
trialled various combinations of concept headings and 
search terms before settling on a broad search strategy, 
accepting that we would obtain a large volume of papers of 
high specificity and low sensitivity.
Screening papers for inclusion was performed by D.W., 
with queries pertaining to inclusion discussed with 
F.E.M.M.
Data sources
The following databases were searched from inception to 
week 2 March 2018: MEDLINE, Embase, CINAHL, 
PsycINFO and The Cochrane Database of Systematic 
Reviews. We also searched Grey literature (Open Grey 
Database), reference lists of included papers and relevant 
systematic reviews identified during screening. Pre-
determined inclusion and exclusion criteria were applied 
during screening.
Inclusion criteria
Empirical research included descriptions of, or references 
to, patient empowerment within their results, irrespective 
of whether empowerment featured in the objectives of the 
study. Included studies report solely on adult patients 
(>18 years of age) with end-stage, advanced, terminal 
and/or life-limiting illness and/or who were defined as 
receiving non-curative management or palliative care sup-
port. We utilised the master search strategy developed by 
Sladek et al.20 to support the capture of literature relevant 
to palliative care in general medical journals.
We included studies incorporating a mix of participants, 
including informal carers and HCPs, only in circumstances 
where patient reported data could be separated and 
extracted. In recognition of variations in service provision 
and healthcare constructs internationally,21,22 we selected 
to focus on features of empowerment specific to patients.
For the purposes of the interpretative review, we retained 
and kept separately papers, identified during screening, that 
were clearly concerned with aspects of patient empower-
ment but included participants with a mixture of both 
advanced life-limiting disease and a range of other disease 
states/stages. These papers were later used to compare 
empowerment themes between the other disease groups 
and patients with advanced life-limiting disease to support 
the dialectic processes of the interpretive review.
Exclusion criteria
To capture generalisable features of empowerment in this 
patient group, we excluded studies with single decision-
specific foci, for example, decisions to withdraw dialysis 
and advance care planning for single-disease groups. 
Conference abstracts and non-empirical papers were also 
excluded. There were no language limitations.
We excluded fatally flawed papers identified using the 
quality appraisal criteria (as cited by Dixon-Woods 
et al.18):
•• Are the aims and objectives of the research clearly 
stated?
•• Is the research design clearly specified and appro-
priate for the aims and objectives?
•• Do researchers provide a clear account of the pro-
cess by which their findings were produced?
•• Do the researchers display enough data to support 
their interpretations and conclusions?
•• Is the method of analysis appropriate and adequately 
explicated?
Each potentially included paper was scrutinised, using 
these criteria, and discussed by at least two of the authors 
(D.W., J.B. and F.E.M.M.) before deciding on inclusion or 
exclusion.
Synthesis
First, we considered the context and potential influences 
and assumptions that underpinned the results related to 
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empowerment. Second, we contrasted the data against 
the retained purposive selection of papers that included a 
mixture of participants with both advanced life-limiting 
disease and a range of other disease states/stages. We 
contrasted papers to observe and address any gaps, to 
ensure that the papers solely describing our population of 
interest were adequately addressing the subject matter, 
while also constantly testing and challenging our emerg-
ing theories against the available evidence for other 
patient populations. Third, we mapped the results to a 
variety of existing frameworks and models of empower-
ment originally designed for patients with long-term con-
ditions and/or non-specific patient groups.4,5,16,23,24 This 
process, which involved repeated evaluation and testing 
of the data, created opportunities to observe whether 
interpretations altered when applying a variety of per-
spectives during the mapping process. This exposed the 
contrasting features of empowerment for our population 
of interest when compared to the patient groups repre-
sented by the models and frameworks. The mismatch 
between existing models and our data demonstrated the 
inadequacy of the models in describing patient empower-
ment in advanced disease and prompted our generation of 
a new conceptual model.
Of the included studies, 25% were randomly selected 
and dual coded (J.B. and D.W.) to enhance reliability 
alongside regular meetings to discuss all aspects of the 
design and conduct of this review (D.W. and F.E.M.M.).
Results
A total of 20,591 papers were screened, but only 13 papers 
met our inclusion criteria after quality assessment (Figure 1). 
Countries represented across the 13 papers were the United 
Kingdom (n = 5),25–29 the United States (n = 3),27,30,31 Australia 
(n = 3),31–33 Ireland (n = 2),27,34 the Netherlands (n = 1)35 and 
Norway (n = 1).36 There were seven qualitative studies and 
six mixed method studies, the characteristics of which are 
summarised in Tables 1 and 2, respectively.
Data were of three types: patient quotes,27-29 the author’s 
words when discussing the study results25, 26, 29-33, 35-37 and 
the reported outcome/s of interventions. Of the 13 studies, 
7 included participants with cancer diagnoses, while the 
remaining 6 included a mix of cancer and non-cancer 
patient groups. No discernible differences were identified 
between the cancer and non-cancer groups with respect to 
patient empowerment.
Two papers had the stated aim of exploring empower-
ment in our population of interest.27,33 We were unable to 
identify any interventions designed with the specific aim 
of empowering patients with advanced disease. Six papers 
evaluated interventions, referencing patient empowerment 
as an incidental outcome.28,29,31,34,36,37 The remaining five 
papers, referencing empowerment within their results, 
were qualitative studies exploring living with multiple 
symptoms,32 experiences of uncertainty,25 the concept of 
chronic cancer,26 relational ethics of hope35 and experi-
ences of self-management.30
The interventions associated with empowering patient 
outcomes included single-component interventions 
(Question Prompt Lists, Patient Satisfaction Questionnaires 
and a Patient-Reported Outcome Measure) and complex 
interventions (Breathlessness Support Service, lifestyle 
interventions and multi-component educational and care 
management palliative care intervention).
Our critical interpretative synthesis generated five 
overarching themes, illustrated in Table 3 (Appendix 2) 
and discussed in the following. The proposed conceptual 
model (Figure 2.) illustrates the interplay and relationships 
of these themes.
Self-identity
Eight papers described the importance of self-identity as 
both a process to becoming empowered and being empow-
ered. Self-identity, in the context of empowerment, reflects 
the beliefs a patient has about themselves, expressed, 
although not exclusively, in terms of self-esteem, self-
image and ideal-self.
Maintaining routines, particularly with respect to per-
sonal-care activities, positively benefitted autonomy and 
self-esteem, reinforced by HCPs or families encouraging 
patient involvement in daily basic and important decisions. 
Maintaining a daily schedule was also described as a moti-
vating element to ‘keep living in the face of death’.33 
However, the ability for patients to control or partake in 
daily basic care activities was challenged by the timeta-
bling of care and imposition of non-negotiable health and 
social care both in community and hospital settings.27,33 
This blanket caregiving created a ‘defy or comply’ 
response from patients, depending on their strength and/or 
confidence to challenge professionals.33
Receiving the respect of others, reflected in being 
acknowledged, and being afforded privacy and inclusion 
despite disability were key features of empowerment.27,28,33,36 
Experiencing overt changes to one’s physical appearance, 
described by one patient as ‘shrinking’, poses a significant 
threat to confidence and generates a fear that others will fail 
to recognise patients’ power, identity and capabilities as 
bodies transform.33
Personalised knowledge in theory and in 
practice
The need for personalised illness education that empha-
sises the pathophysiology of symptoms to support under-
standing of symptom management emerged as a component 
of becoming empowered. Merely providing knowledge 
and skills around symptom management was highlighted 
as insufficient.27 Personalised information provision, at the 
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patient’s pace, that included the expected symptom trajec-
tory and more generally ’what to expect’, was reportedly 
empowering.29,30
Mikkleson et al.36 report on the benefits of a ‘healthy’ 
lifestyle educational intervention, emphasising the contin-
ued desire to be ‘healthy’ and make ‘healthy choices’ even 
in the advanced stages of illness, as a mechanism for 
regaining control, which promoted confidence and coping. 
The need to personalise and pace these approaches was 
also reported after patients expressed feelings of guilt 
when failing to achieve mutually designed ‘goals’.36
In congruence with the findings from other patient popula-
tions, having knowledge and skills encouraged patient partici-
pation in self-management, enhancing confidence and 
renewing a sense of self-responsibility and motivation.26,29,34,36 
In contrast, desire for self-management education was often 
tempered by the patient’s ‘ability’ to consider further, inevitable 
losses. In this patient group, self-management education 
should be delivered sensitively and in a personalised manner 
which respects changes in capacities, capabilities and priori-
ties over time.
Negotiating personal and healthcare 
relationships
Eight studies explored features of personal and healthcare/
professional relationships that enabled and sustained a 
sense of empowerment for patients. The qualities advo-
cated applied to HCPs, families, informal carers, patients 
and services, with the synergy between these groups inte-
gral in the attainment of empowerment. Empowering part-
nerships were fostered by families and HCPs ‘being and 
Figure 1. PRISMA flow diagram.
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listening’ rather than ‘doing’, reinforcing equality, respect 
and therein the patient’s self-identity.31–33,37 Central to these 
partnerships was engaging patients in their care rather than 
resigning them to a passive role in paternalistic, overly nur-
turing relationships. Owing to the deleterious effects of 
advancing disability, relationships and roles needed con-
stant re-evaluation. In this context, empowered exchanges 
involved patients negotiating the offers of support from 
HCPs or families and protecting the proportion of the pro-
posed activity that can be achieved independently.33,36
HCPs needed to communicate in an unrushed, empathic, 
honest and inclusive fashion,31,32 tailoring patient-centred 
decision-making to support the preferences and values of 
the patient over time. Clinicians over-emphasising patient 
choice/autonomy in efforts to empower patients (e.g. by 
‘dumping’ information on them rather than collaborating 
in decision-making), conversely resulted in patients feel-
ing abandoned and disenfranchised.31 In addition, respect-
ing the preference of some patients to pass on responsibility 
for decision-making can be an empowering demonstration 
of wishes for patients.31
There is evidence that for some patients, desire for open 
and honest communication can be restricted by the fear of 
losing hope, based on either previous experience or an 
expectation of clinicians censoring hope when communicat-
ing with complete honesty in the context of life-limiting ill-
ness. This is reflected in the works of Richardson et al.33 and 
Olsman et al.35 where patients describe the desirable ability 
of HCPs to ‘protect hope’ to enable patients to retain a degree 
of positivity for the future in spite of their prognosis.
Possessing the confidence to seek help from others, both 
family and HCPs, was also a feature of empower-
ment.28,31,34,36,37 Obtaining permission to seek the help was 
intrinsic to this process, three of the included studies described 
interventions that supported patients’ interaction and discus-
sions with HCPs.31,34,37
Acknowledgement of terminal illness
Studies described a point where by patients acknowledged 
their impending death, inclusive of the stark realities of 
what that might mean for their physical and mental capaci-
ties, in order to regain a sense of control. In this context, 
control was signified through sorting affairs and making 
decisions in response to the limitations placed on their life 
expectancy.25 Control was also manifested through patient-
led ‘handing over’ of physical tasks to family or HCPs to 
facilitate the reassignment of energy to alternative tasks/
focuses.33 While one study stated that empowerment could 
not truly be achieved without people acknowledging their 
mortality and the consequences of progressive disability,30 
others provided examples of patients feeling empowered, 
having stated their wish to avoid discussions around their 
mortality and future losses.33
Navigating continued losses
Adaptation to, and coping with, continuous physical and 
social losses was cited as a key feature of becoming and 
being empowered in five papers. Adaptation was achieved 
through changing priorities, sorting personal affairs and 
planning for further deteriorations.25,27,30 Coping involved 
refocusing on small daily tasks.33
Having hope was central to the patient’s capacity for 
adaptation and coping, with hope a motivating element to 
‘go on’ as losses continued to manifest.33 The fragility of 
hope and therein one’s ability to cope and continue was 
recognised as being under continuous threat.30
Figure 2. Proposed conceptual model of patient empowerment for adults with advanced life-limiting illness.
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Possessing the skills and capacity to continually adapt, 
and remain resilient to, loss provided opportunity to 
achieve or regain a sense of feeling ‘in control’.30 The 
presence or absence of control thus emerged as a key mod-
erator to being or becoming empowered.
Themes within the conceptual model
‘Self-identity’, as a central feature of patient empower-
ment, includes preserving, enhancing and communicating 
self-identity. It reflects the importance placed on identity 
for self (the patient), relationships and society. In the theo-
retical model, each theme has a potentially mutually influ-
ential relationship with self-identity.
An example of this is demonstrated by Richardson 
et al. in their qualitative interview study exploring issues 
surrounding empowerment and daily decision-making 
with 11 terminally ill hospice in-patients. Patients associ-
ated negotiating offers of care and inclusion in therapeutic 
relationships with strengthened self-identity; this miti-
gated the challenges to self-image and self-identity pro-
duced by the negative appearance-altering manifestations 
of their illness.33
Olsman et al. investigated the relationship between hope 
and empowerment through interviews with 29 patients 
receiving specialist palliative care support. Patients needed 
HCPs to convey hope of what still can be done. Patients 
‘having hope’ were protective against the reality of termi-
nal illness, including potential functional losses. Retaining 
hope consequently enhanced capacities to acknowledge 
and manage transitions in their illness and made patients 
feel more powerful. This resulted in HCPs ‘recognising 
patients own power, in spite of severe illness’.35
‘Acknowledgement of terminal illness’ and ‘Navigating 
continued losses’ themes within the model represents fea-
tures felt by patients to be inescapable in the advanced 
stages of life-limiting illness. These, like all the themes 
identified, were expressed to different degrees within the 
literature. An example is provided by Olsman et al.35 when 
a patient, not wishing to acknowledge her terminal diagno-
sis with HCPs, communicated this preference to help nego-
tiate these relationships and felt empowered as a result.
‘Personalised knowledge in theory and in practice’ and 
‘Negotiating personal and healthcare relationships’ include 
features of empowerment conceptualised as being optional 
for patients to engage with and, when engaged, open to 
influence by patients themselves.
Discussion
Summary of main findings
To our knowledge, this is the first review to explore the 
concept of patient empowerment for adults living with 
advanced, life-limiting illness. Principally, we have 
identified that while there is a paucity of research in this 
area, the evidence available demonstrates the differences 
in the factors/themes associated with patient empower-
ment for adults in the advanced stages of a life-limiting 
illness in comparison to other patient groups. Key differ-
ences relate to the continued physical and psychosocial 
challenges this group encounter, producing contrasting 
patient empowerment foci and outcomes.
Distinct for our population of interest is the experience 
of continued insults and resultant losses that occur within 
short periods of time. Empowerment, when you are dying, 
includes the capacity to withstand insults and losses which 
may compromise, in particular, a patient’s self-identity. 
Protecting self-identity is central to empowerment for 
this group and represents a key motivator to ‘continue 
living’,33 in comparison to other patient groups, where 
enhanced or sustained health states are seen as both a moti-
vator and outcome of empowerment.4,38,39
From the literature focused on patients with long-term 
conditions (the group that empowerment strategies have 
largely evolved to target), a key empowerment outcome is 
aimed towards enhancing patients ‘feelings of control over 
their illness’.5,13,15 In contrast, an outcome or focus for 
empowered patients with terminal illness appears to centre 
around self-identity, as opposed to control of their illness 
or health state(s). For example, this review found that 
patients placed stronger emphasis on the benefits of equi-
table therapeutic relationships with HCP with respect to 
self-identity (feeling respected and valued),27,33,35 rather 
than focusing on the product of that relationship being to 
enhance their ‘feelings of control over their illness’.
Furthermore, relationships with HCP and families, for this 
group, evolve more readily owing to persistent losses and 
often inevitable physical or cognitive dependency. There is a 
delicate need for shifting responsibilities over time, with 
points at which the patient ‘hands over’ increasingly to others. 
Recognising evolving physical limitations and letting others 
‘do’ can instil a sense of control so long as it is balanced and 
paced to the patients preference and is not restricted by time-
tabled, non-personalised care. This is in contrast to the focus 
on persistently equal relations and responsibilities for HCP/
families and patients in other groups.4,7,15
Our review identified just two papers that sought to 
explore empowerment as a study objective.27,33 Richardson 
et al. explored the meaning of empowerment and decision-
making from the perspectives of 11 patients in receipt of 
specialist palliative care support, while Selman et al. stud-
ied the challenges to and facilitators of empowerment in an 
ethnographic study interviewing 26 patients aged 
⩾65 years receiving specialist palliative care. Both papers 
communicate the emphasis placed, by patients, on rela-
tionships and services that enable them to attain and retain 
respect, acknowledgement and inclusion.
We did not identify any papers evaluating interventions 
designed to empower patients with advanced disease. The 
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five mixed method studies that evaluated interventions ref-
erenced empowerment as an incidental outcome. In con-
trast, Bravo et al.4 identified 67 studies with published 
definitions of patient empowerment for patients with long-
term conditions. Barr et al.5 identified 30 studies on 19 
measures of empowerment for a range of patient groups, 
although none designed specifically for patients with 
advanced, life-limiting conditions.
Limitations
The terms ‘patient empowerment’ and ‘patient activation’ 
largely occur within research and policy in developed, 
high-income countries and might not translate across all 
countries and cultures. We retained studies that exclusively 
included and defined patients as being in the advanced 
stages of life-limiting illness. Not all papers report the 
phase/stage of illness of participants, so we might have 
missed papers that might have contributed to the aims of 
this study.
Implications for policy, research and practice
Our review found no evidence of attempts to incorporate 
patient empowerment into the design or evaluation of ser-
vices that support people with advanced life-limiting ill-
ness. In contrast, there is a significant body of work in this 
area for patients with long-term conditions and as part of 
population health-promotion strategies.12,13,40,41
We suggest, based on the findings from this review, 
that current programmes and measures of patient empow-
erment may not be wholly applicable to patients with 
advanced, life-limiting disease. First, many of these 
existing approaches assume a role for prevention of nega-
tive health states or promotion of lifestyle measures to 
benefit health states.15 Second, there is little research 
addressing and/or managing the irreversible aspects of 
health states.40 Third, there may be additional dimensions 
and aspects of empowerment in advanced illness, as 
described in the opening of our discussion. On this basis, 
we would argue that presently there is no reliable and 
valid way to assess whether existing services and struc-
tures are or are not empowering to patients with advanced, 
life-limiting disease.
The findings of this review highlight the desire of 
many patients to remain actively involved in decisions 
about, and in the practice of, their care. To this effect, we 
suggest that services should aim to support and promote 
empowerment. The emerging use of discrete choice 
experiments in service assessment and design42,43 may 
offer a method to maintain patient inclusion and support 
the generation of services that will benefit patient empow-
erment in tandem. In addition, interventions shown to 
empower patients should be incorporated into routine 
practice; these include interventions that support patient 
and HCP dialogue28,31 and involve personalised lifestyle 
and self-management advice.29,36,37
Conclusion
This review provides an evidence base and conceptual 
model to inform future research into patient empower-
ment for patients with advanced life-limiting illness. 
Being an ‘empowered patient’, when living with 
advanced life-limiting illness is different to the experi-
ence and meaning of empowerment for other patient 
groups. ‘Patient empowerment’ emerges as a metaphor 
for all that enables people to maintain their self-identity 
until the very end of life.
Considering the benefits of services and programmes 
designed to empower patients in other groups, further 
research is needed to ensure end-of-life care is optimally 
empowering. We would propose that the themes of this 
review may provide a useful starting point to guide the 
assessment of existing services and development of a new 
dialogue surrounding patient participation in the design of 
services and interventions.
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Appendix 1
1. Database search details and search terms used for review
   MEDLINE via Ovid (Inception to week 2 March 2018)
   EMBASE via Ovid (Inception to week 2 March 2018)
   CINAHL via EBSCOhost (Inception to week 2 March 2018)
   PsycINFO via Ovid (Inception to week 2 March 2018)
   Cochrane Database of Systematic Reviews (Inception to week 2 March 2018)
2. Medline (OVID) search strategy
Search terms
1 *Patient Participation/
2 *Self Care/
3 empowerment.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword]
4 *Self Efficacy/
5 mastery.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
6 *Self-Control/
7 control.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
8 *Self Concept/
9 *Internal-External Control/
10 confidence.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
11 *Decision-Making/
12 *Attitude to Health/
13 *Motivation/
14 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13
15 end-of-life*.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
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Search terms
16 (advanced adj3 (disease or condition or illness)).mp. [mp = title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword]
17 (progressive adj3 (disease or condition or illness)).mp. [mp = title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword]
18 palliat$.tw.
19 hospice$.tw.
20 *Palliative Care/
21 *Terminal Care/
22 *Terminally Ill/
23 *Hospices/
24 terminal-care.tw.
25 (activat* or partcipat* or empower* or engag* or decision* or self* or confiden* or master* or belie*).mp. [mp = title, 
abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword]
26 *Death/
27 *Bereavement/
28 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 26 or 27
29 14 and 28
30 25 and 29
3. Search terms by database
Search terms – Medline (OVID)
*MeSH heading
.mp. = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword]
*Patient Participation
*Self Care
*Self Efficacy
*Self-Control
*Self Concept
*Internal-External Control
*Decision-Making
*Attitude to Health
*Motivation
empowerment.mp.
mastery.mp.
control.mp.
confidence.mp.
*Palliative Care
*Terminal Care
*Terminally Ill
*Hospices
*Death
*Bereavement
end-of-life*.mp.
(advanced adj3 (disease or condition or illness)).mp.
(progressive adj3 (disease or condition or illness)).mp.
(activat* or partcipat* or empower* or engag* or decision* or self* or confiden* or 
master* or belie*).mp.
terminal-care.tw.
palliat$.tw.
hospice$.tw.
Search terms – Embase(OVID)
*MeSH heading
.mp. = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword
*Patient Participation
*Self Care
*Self Efficacy
*Self-Control
*Self Concept
*Internal External Locus of Control
*Decision-Making
*Health Attitudes
*Motivation
empowerment.mp.
mastery.mp.
control.mp.
confidence.mp.
*Palliative Care
*Terminal Care
*Terminally Ill Patients
*HOSPICE
*‘death and dying’
*Bereavement
end-of-life*.mp.
(advanced adj3 (disease or condition or illness)).mp.
(progressive adj3 (disease or condition or illness)).mp.
(activat* or partcipat* or empower* or engag* or decision* or self* or confiden* or 
master* or belie*).mp.
terminal-care.tw.
palliat$.tw.
hospice$.tw.
 (Continued)
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Search terms – CINAHL (EBSCO)
MM – Searches the exact CINAHL® subject heading; searches just for major headings,
MW – Searches for a word in the CINAHL® subject heading, including subheadings, retrieves citations indexed under major or 
minor.
Article Title (TI), Abstract (AB), Within three words of (n3)
‘patient participation’
(MM ‘Self Care’)
(MM ‘Self-Efficacy’)
(MM ‘self control’)
(MM ‘Self Concept’)
(MM ‘Locus of Control’)
(MM ‘Decision Making, Patient’)
(MM ‘Attitude to Health’)
(MM ‘Motivation’)
(MM ‘Attitude to Illness’)
(MM ‘Empowerment’)
(MM ‘mastery’)
(MM ‘Confidence’)
(MM ‘Palliative Care’)
(MM ‘Terminal Care’)
(MM ‘Terminally Ill Patients’)
(MM ‘Hospices’)
(MM ‘Death’)
*Bereavement/
‘end of life*’
TI ( ((advanced) n3 (disease* or condition* or illness*)))) OR AB ( ((advanced) n3 (disease* 
or condition* or illness*))))
TI ( ((progressive) n3 (disease* or condition* or illness*))) OR AB ( ((progressive) n3 
(disease* or condition* or illness*)))
TI ( (activat* or partcipat* or empower* or engag* or decision* or self* or confiden* or 
master* or belie*)) OR AB ( (activat* or partcipat* or empower* or engag* or decision* or 
self* or confiden* or master* or belie*)) OR MW ( (activat* or partcipat* or empower* or 
engag* or decision* or self* or confiden* or master* or belie*))
‘“terminal-care”’
‘palliat*’
‘hospice*’
Search terms – PsycINFO (OVID)
*MeSH heading
.mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword]
*Patient Participation
*Self Care
*Self-Control
*Self Concept
*Control
*Decision-Making
*Attitude to Health
*Motivation
empowerment.mp.
mastery.mp.
control.mp.
confidence.mp.
*palliative therapy
*Terminal Care
*terminally ill patient
*Hospices
*Death
*Bereavement
end-of-life*.mp.
(advanced adj3 (disease or condition or illness)).mp.
(progressive adj3 (disease or condition or illness)).mp.
(activat* or partcipat* or empower* or engag* or decision* or self* or confiden* or 
master* or belie*).mp.
terminal-care.tw.
palliat$.tw.
hospice$.tw.
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Appendix 2
Table 3. Study findings related to empowerment mapped to themes.
Self-identity Personalised knowledge 
in theory and in practice
Acknowledgement of 
terminal illness
Negotiating personal and 
healthcare relationships
Navigating continued 
losses
Preserved dignity32
Feeling respected35
Privacy27
Desire for respect, 
being valued, 
acknowledged27
Being valued and 
respected33
Preserve autonomy33
Feeling valued ‘useful’36
Confidence36
Managing planned 
activities36
Ability to perform 
& maintain personal 
care33
Need for preservation 
of routine ADLs > to 
keep motivation to 
live33
Individual engagement 
33
Confidence34
Daily involvement in 
basic and important 
decisions 33
Opinions being 
valued28
Self-Control26
Preserved autonomy32
Validation of symptom 
experience34
Enhanced feeling 
of control over 
illness through 
taking ownership of 
symptoms34
Health ‘situation’-
knowledge36
Health ‘situation’-
understanding36
Self-management 
promoting a sense of 
‘control’26
Self-management30
‘Healthy’ Lifestyle 
education > control, 
confidence,coping36
Self-management 
(obtaining knowledge 
and skills)30
Understanding of 
illness29
Understanding of 
symptom trajectory29
Illness education29
Balance of goal setting 
being motivating-
confidence, coping-
when achieved but 
equally36
Guilt on failing to reach 
goals and a loss of 
motivation36
Accepting the need for 
assistance/help33
Acknowledge disease 
progression > control 
to sort affairs33
Acknowledge and 
Accept lack of control 
over course of 
illness > control and 
autonomy33
Acknowledge 
uncertainty26
Accepting terminal 
diagnosis32
Address and Sort 
affairs26
Planning for future 
deteriorations in 
health36
Continuity and coordination 
of care32
HCPs communicating with 
compassion32
Carers supporting patients 
psychological state(s)32
HCPs protecting hope35
Need for partnerships with 
HCPs33
Empathic, active listening 
relationships33
Preference for listening/
being vs people ‘doing’ 33
Feeling supported 33
HCPs to avoid abandoning 
patients with decision-
making27
Opportunity to discuss 
preferences27
Exploring patient’s own idea 
of ‘autonomy’27
Unrushed communication 
with HCPs27
Obtain preferences for 
decision-making27
Confidence for inclusion27
Confident to ask for support 
and time from HCPs30
Honest communication with 
HCPs27
Holistic needs assessment 
supports, vocabulary and 
therein dialogue with 
HCPs34
Question prompt lists aid 
and/or prompts dialogue30
Being involved in care 
decisions/experience28
Feeling secure and 
understood32
Being heard28
Express opinions28
Confidence to ask HCPs 
about prognosis/future 
care30
Confidence to seeking 
assistance from HCPs31
Support/encouragement to 
seek help31
Discussions, rather than 
‘consultations’30
Being confident to express 
limitations/disability35
Hope as a motivator, 
to ‘go on’/stay alive33
Accept uncertainty25
Coping36
Changing priorities33
Resilience to/coping 
with threats to hope33
Adaptation to 
continued losses/
forfeitures physical 
and social33
Adapting to physical/
self-image changes33
Power to manage 
losses – regaining 
internal control33
Taking an active role 
in health-related 
issues – planning for 
future deteriorations 
in health36
Coping with the 
impacts of shrinking 
body/bodily functions 
on identity33
Hope35
Power35
Active (rather than 
passive) role in health 
care/management34
ADLs: activities of daily living; HCPs: healthcare professionals.
